Latest Stem Cells news
Age, Disease Duration Are Predictors of CKD After Stem Cell Transplant
posted August 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Allogeneic HCT Feasible in Older Patients With Myelodysplastic Syndrome
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
posted December 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Stem Cell Treatment Feasible for Aniridia-Related Keratopathy 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy Related Articles
A-Fib Occurs Frequently in Patients With Multiple Myeloma Undergoing Stem Cell Transplant 
Guidelines Issued for Management of Acute Lymphoblastic Leukemia in Teens, Young Adults 
Liberalized Diet Not a Safe Alternative to Neutropenic Diet in Adults Being Treated for Acute Leukemia 
Intracoronary Infusion of Mesenchymal Stem Cells Beneficial in STEMI Monthly Specialist Briefings
Stay Connected
